Find, compare & contact
Dl-tropyltropate (Atropine) API Manufacturers & Suppliers

Looking for Atropine API 51-55-8?

Description:

Here you will find a list of producers, manufacturers and distributors of Atropine. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Atropine 

Synonyms:

Atropin , Atropina , Atropine , Atropinum , dl-Hyoscyamine , dl-tropyltropate , Mydriasine , Tropine tropate , Atropini , Atropine sulfate  

Cas Number:

51-55-8 

DrugBank number:

DB00572 

Unique Ingredient Identifier:

7C0697DR9I

Atropine is a type of Anticholinergics/Parasympathemimetics

Anticholinergics/Parasympathomimetics are a subcategory of pharmaceutical active pharmaceutical ingredients (APIs) widely used in the medical field. These compounds exhibit specific pharmacological actions by targeting the cholinergic system in the body.

Anticholinergics are drugs that block the action of acetylcholine, a neurotransmitter that regulates various bodily functions. By inhibiting the activity of acetylcholine, anticholinergics can have diverse therapeutic effects, including reducing muscle spasms, decreasing gastrointestinal motility, and alleviating symptoms associated with certain respiratory conditions.

On the other hand, parasympathomimetics, also known as cholinomimetics, mimic the action of acetylcholine by stimulating cholinergic receptors. These compounds enhance the parasympathetic nervous system, which is responsible for the "rest and digest" functions of the body. Parasympathomimetics are commonly used to treat conditions such as glaucoma, urinary retention, and Alzheimer's disease.

The use of anticholinergics/parasympathomimetics requires careful consideration and medical supervision due to their potential side effects, which can include dry mouth, blurred vision, urinary retention, constipation, and cognitive impairment. These medications are available in various forms, including tablets, capsules, patches, and inhalers, and their dosage is determined by the specific medical condition being treated.

Overall, anticholinergics/parasympathomimetics play a vital role in modern medicine, providing targeted therapeutic effects by modulating the cholinergic system. Their usage has significantly improved patient outcomes in various medical conditions and continues to be an important category of pharmaceutical APIs.

Atropine (Anticholinergics/Parasympathemimetics), classified under Autonomic Nervous System Agents

Autonomic Nervous System Agents are a crucial category of pharmaceutical active ingredients (APIs) that target the autonomic nervous system (ANS). The ANS plays a vital role in regulating essential bodily functions such as heart rate, blood pressure, digestion, and respiratory rate. This category of pharmaceutical APIs encompasses a wide range of drugs designed to modulate the activity of the ANS.

One subcategory within Autonomic Nervous System Agents is the Sympathomimetic agents, which mimic the effects of the sympathetic nervous system. These drugs are often used to treat conditions such as asthma, nasal congestion, and hypotension by stimulating specific adrenergic receptors.

Conversely, Sympatholytic agents act to inhibit or block the sympathetic nervous system. They are employed to treat hypertension, anxiety, and certain cardiac conditions by reducing sympathetic activity.

Another subcategory is Parasympathomimetic agents, which mimic the effects of the parasympathetic nervous system. These drugs are commonly used to treat glaucoma, urinary retention, and certain gastrointestinal disorders by stimulating cholinergic receptors.

Parasympatholytic agents, on the other hand, act to block the parasympathetic nervous system. They find applications in the treatment of conditions such as overactive bladder and irritable bowel syndrome by inhibiting cholinergic receptors.

The Autonomic Nervous System Agents API category includes various drugs with distinct mechanisms of action that enable healthcare professionals to fine-tune the balance of the autonomic nervous system. By targeting specific receptors and pathways, these pharmaceutical APIs provide valuable therapeutic options for managing a wide range of medical conditions related to autonomic dysfunction.

• Caesar & Loretz GmbH (CAELO) from Germany, product country of origin India
• Nanjing Hanxin Pharmaceutical Technology Co.,Ltd. from China, product country of origin China
• Duchefa Farma B.V. from Netherlands, product country of origin China
• Aurora Industry Co., Ltd from China, product country of origin China
• Jiwan Pharmaceutical Technology Co.,Ltd from China, product country of origin China
• Rolabo Outsourcing from Spain, product country of origin Spain
• Kinsy from Spain, product country of origin Spain
• Hubei Biocause from China, product country of origin China
• Cedarburg Pharma from United States, product country of origin United States
• Laurus Labs from India, product country of origin India
• Katsura Chemical from Japan, product country of origin Japan
• TIEFENBACHER API + Ingredients from Germany, product country of origin Unknown
• Mylan from India, product country of origin India
• Resonance Labs. from India, product country of origin India
• Boehringer Ingelheim from Germany, product country of origin Unknown

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.